Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients

Figure 13

The enrichment analysis of lipid differential compounds. (a) Overview of enriched metabolite sets between NSCLC patients of pre-RT group and healthy controls. (b) Metabolite set enrichment overview between NSCLC patients of pre-RT group with bad and good responses.

(a)

(b)